Sage Journals: Discover world-class research

Free access

Research article

First published 2016-4

Soluble Programmed Death 1 (PD-1) Is Decreased in Patients With Immune Thrombocytopenia (ITP)

Elif Birtas Atesoglu, Pinar Tarkun, Esra Terzi Demirsoy [...]

Clinical and Applied Thrombosis/Hemostasis

Retricted access

Abstract

First published 2020-4

The Study of Programmed Death-1 Receptor,Programmed Death-1 Ligand (Pd-1/Pd-L1) and Apoptosis in Breast Cancer Patients: A Potential Mechanism of Immune Escape

S.A Ali, A.N El-Daly, A El-Sayed [...]

Tumori Journal

Open access

Research article

First published 2018

Diverse cutaneous adverse eruptions caused by anti-programmed cell death-1 (PD-1) and anti-programmed cell death ligand-1 (PD-L1) immunotherapies: clinical features and management

John Shen, Jason Chang, Melody Mendenhall [...]

Therapeutic Advances in Medical Oncology

Retricted access

Case report

First published 2020-4

Programmed Death 1 Inhibitor–Induced Hypothyroidism on the Palliative Care Unit: Case Report

Kelvin Lou, Shalini Nayar

Journal of Palliative Care

Open access

Review article

First published 2021-03-23

PD-L1 Expression and Treatment Implications in Metastatic Clear Cell Renal Cell Carcinoma: A Systematic Review

Albert Jang, Patrick L. Sweeney, Pedro C. Barata [...]

Kidney Cancer

Retricted access

Review article

First published 2018-1

The Emerging Role of PD-1/PD-L1–Targeting Immunotherapy in the Treatment of Metastatic Urothelial Carcinoma

Morgan E. Gwynn, David L. DeRemer

Annals of Pharmacotherapy

Retricted access

Abstract

First published 2021-6

Study of Gene Expression of Programmed Cell Death Ligand 1 (PD-L1) in Breast Cancer Patients

H Gadelrab, M Mokhtar, H Morsy [...]

Tumori Journal

Retricted access

Review article

First published 2025

The Prognostic Significance of Programmed Death-Ligand 1 (PD-L1) in Skin Neoplasms: A Systematic Review and Meta-Analysis

Alireza Abdollahi, Emad Mehrtash, Bita Jafarzadeh [...]

International Journal of Surgical Pathology

Open access

Research article

First published 2025

Relationship between HBsAg/HBV DNA and prognosis in patients with HBV-related hepatocellular carcinoma treated with PD-1/PD-L1 inhibitors

Qiuying Qin, Yuanyuan Zheng, Yiran Wang [...]

Therapeutic Advances in Medical Oncology

Free access

Case report

First published 2017

Severe Exacerbation of Myasthenia Gravis Associated with Checkpoint Inhibitor Immunotherapy

Dana S. Cooper, Matthew N. Meriggioli, Philip D. Bonomi [...]

Journal of Neuromuscular Diseases

Search results